Intervention Protocol

You have free access to this content

Vitamin D supplementation for sickle cell disease

  1. Htoo Htoo Kyaw Soe1,*,
  2. Adinegara BL Abas1,
  3. Nan Nitra Than1,
  4. Han Ni2,
  5. Jaspal Singh3,
  6. Abdul Razzak Bin Mohd Said4,
  7. Ifeyinwa Osunkwo5

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 29 NOV 2013

Assessed as up-to-date: 27 NOV 2013

DOI: 10.1002/14651858.CD010858

How to Cite

Soe HHK, Abas ABL, Than NN, Ni H, Singh J, Said ARBM, Osunkwo I. Vitamin D supplementation for sickle cell disease (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010858. DOI: 10.1002/14651858.CD010858.

Author Information

  1. 1

    Melaka-Manipal Medical College (MMMC), Department of Community Medicine, Melaka, Malaysia

  2. 2

    SEGi University, Internal Medicine, Teluk Intan, Perak Darul Ridzuan, Malaysia

  3. 3

    Melaka-Manipal Medical College, Faculty of Medicine, Melaka, Malaysia

  4. 4

    Melaka-Manipal Medical College, Melaka, Malaysia

  5. 5

    Aflac Cancer and Blood Disorders Service, Emory University School of Medicine, Comprehensive Sickle Cell Program, Atlanta, Georgia, USA

*Htoo Htoo Kyaw Soe, Department of Community Medicine, Melaka-Manipal Medical College (MMMC), Jalan Batu Hampar, Bukit Baru, Melaka, 75150, Malaysia.

Publication History

  1. Publication Status: New
  2. Published Online: 29 NOV 2013




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the effects on general health, bone and respiratory health, and the safety of vitamin D supplementation in children and adults with SCD.

To investigate the hypothesis that vitamin D supplementation increases serum 25-hydroxyvitamin D level in children and adults with SCD.